LAMPIRAN
Lampiran 1 Dokumentasi penelitian
Gambar 1. Mencukur Rambut Tikus Gambar 2. Tikus Sesudah Dicukur
Gambar 3. Pengukuran Luka Insisi Gambar 4. Proses Insisi
Gambar 5. Tikus Sesudah Diinsisi Gambar 6. Terapi dengan Bubuk Kopi
Gambar 7. Luka Setelah Diberi Bubuk Kopi
Gambar 8. Terapi Menggunakan
Neomisin-Basitrasin
Lampiran 2 Persetujuan Etik
Lampiran 3 Data Penelitian Crosstabs
Case Processing Summary Cases
Valid Missing Total
N Percent N Percent N Percent
oozingH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%
oozingH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%
oozingH7 * Kelompok Crosstabulation
Kelompok Total
Serbuk Kopi Robusta
Serbuk Basitracin
Kontrol
oozingH7
Permukaan Basah
Count 0 1 0 1
% within Kelompok
0,0% 20,0% 0,0% 6,7%
Permukaan Basah Berkurang
Count 0 0 5 5
% within Kelompok
0,0% 0,0% 100,0% 33,3%
Permukaan Kering
Count 5 4 0 9
% within Kelompok
100,0% 80,0% 0,0% 60,0%
Total
Count 5 5 5 15
% within Kelompok
100,0% 100,0% 100,0% 100,0%
oozingH14 * Kelompok Crosstabulation
Kelompok Total
Serbuk Kopi Robusta
Serbuk Basitracin
Kontrol
oozingH14 Permukaan Kering
Count 5 5 5 15
% within Kelompok
100,0% 100,0% 100,0% 100,0%
Total
Count 5 5 5 15
% within Kelompok
100,0% 100,0% 100,0% 100,0%
Crosstabs
Case Processing Summary Cases
Valid Missing Total
N Percent N Percent N Percent
tepiH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%
tepiH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%
tepiH7 * Kelompok Crosstabulation
Kelompok Total
Serbuk Kopi Robusta
Serbuk Basitracin
Kontrol
tepiH7
Tepi Kemerahan (+)
Count 0 2 4 6
% within Kelompok
0,0% 40,0% 80,0% 40,0%
Tepi Kemerahan (-)
Count 5 3 1 9
% within Kelompok
100,0% 60,0% 20,0% 60,0%
Total
Count 5 5 5 15
% within Kelompok
100,0% 100,0% 100,0% 100,0%
tepiH14 * Kelompok Crosstabulation
Kelompok Total
Serbuk Kopi Robusta
Serbuk Basitracin
Kontrol
tepiH14
Tepi Kemerahan (+)
Count 1 5 1 7
% within Kelompok
20,0% 100,0% 20,0% 46,7%
Tepi Kemerahan (-)
Count 4 0 4 8
% within Kelompok
80,0% 0,0% 80,0% 53,3%
Total
Count 5 5 5 15
% within Kelompok
100,0% 100,0% 100,0% 100,0%
Crosstabs
Case Processing Summary Cases
Valid Missing Total
N Percent N Percent N Percent
LeukositH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%
LeukositH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%
LeukositH7 * Kelompok Crosstabulation
Kelompok Total
Serbuk Kopi Robusta
Serbuk Basitracin
Kontrol
LeukositH7 Normal
Count 5 5 5 15
% within Kelompok 100,0% 100,0% 100,0% 100,0%
Total
Count 5 5 5 15
% within Kelompok 100,0% 100,0% 100,0% 100,0%
LeukositH14 * Kelompok Crosstabulation
Kelompok Total
Serbuk Kopi Robusta
Serbuk Basitracin
Kontrol
LeukositH14 Normal
Count 5 5 5 15
% within Kelompok 100,0% 100,0% 100,0% 100,0%
Total
Count 5 5 5 15
% within Kelompok 100,0% 100,0% 100,0% 100,0%
Means
Case Processing Summary Cases
Included Excluded Total
N Percent N Percent N Percent
BesarlukaH7 * Kelompok 15 100,0% 0 0,0% 15 100,0%
BesarLukaH14 * Kelompok 15 100,0% 0 0,0% 15 100,0%
Report
Kelompok BesarlukaH7 BesarLukaH14
Serbuk Kopi Robusta
Mean 1,7000 ,5200
Std. Deviation ,10000 ,13038
Median 1,7000 ,5000
Minimum 1,60 ,40
Maximum 1,80 ,70
Serbuk Basitracin
Mean 1,7800 ,8000
Std. Deviation ,08367 ,10000
Median 1,8000 ,8000
Minimum 1,70 ,70
Maximum 1,90 ,90
Kontrol
Mean 3,2020 1,0400
Std. Deviation ,15007 ,11402
Median 3,2300 1,0000
Minimum 3,06 ,90
Maximum 3,42 1,20
Total
Mean 2,2273 ,7867
Std. Deviation ,72205 ,24456
Median 1,8000 ,8000
Minimum 1,60 ,40
Maximum 3,42 1,20
NPar Tests
Kruskal-Wallis Test
Ranks
Kelompok N Mean Rank
oozingH7
Serbuk Kopi Robusta 5 11,00
Serbuk Basitracin 5 9,00
Kontrol 5 4,00
Total 15
oozingH14
Serbuk Kopi Robusta 5 8,00
Serbuk Basitracin 5 8,00
Kontrol 5 8,00
Total 15
tepiH7
Serbuk Kopi Robusta 5 11,00
Serbuk Basitracin 5 8,00
Kontrol 5 5,00
Total 15
tepiH14
Serbuk Kopi Robusta 5 10,00
Serbuk Basitracin 5 4,00
Kontrol 5 10,00
Total 15
LeukositH7
Serbuk Kopi Robusta 5 8,00
Serbuk Basitracin 5 8,00
Kontrol 5 8,00
Total 15
LeukositH14
Serbuk Kopi Robusta 5 8,00
Serbuk Basitracin 5 8,00
Kontrol 5 8,00
Total 15
BesarlukaH7
Serbuk Kopi Robusta 5 4,40
Serbuk Basitracin 5 6,60
Kontrol 5 13,00
Total 15
BesarLukaH14
Serbuk Kopi Robusta 5 3,20
Serbuk Basitracin 5 8,00
Kontrol 5 12,80
Total 15
Test Statisticsa,b oozingH
7
oozingH1 4
tepiH 7
tepiH1 4
LeukositH 7
LeukositH1 4
BesarlukaH 7
BesarLukaH1 4 Chi-
Square
8,667 ,000 6,222 8,000 ,000 ,000 10,274 11,729
df 2 2 2 2 2 2 2 2
Asymp . Sig.
,013 1,000 ,045 ,018 1,000 1,000 ,006 ,003
a. Kruskal Wallis Test
b. Grouping Variable: Kelompok
NPar Tests (kopi robusta) Wilcoxon Signed Ranks Test
Ranks
N Mean Rank Sum of
Ranks
oozingH14 - oozingH7
Negative Ranks 0a ,00 ,00
Positive Ranks 0b ,00 ,00
Ties 5c
Total 5
tepiH14 - tepiH7
Negative Ranks 1d 1,00 1,00
Positive Ranks 0e ,00 ,00
Ties 4f
Total 5
LeukositH14 - LeukositH7
Negative Ranks 0g ,00 ,00
Positive Ranks 0h ,00 ,00
Ties 5i
Total 5
BesarLukaH14 - BesarlukaH7
Negative Ranks 5j 3,00 15,00
Positive Ranks 0k ,00 ,00
Ties 0l
Total 5
a. oozingH14 < oozingH7 b. oozingH14 > oozingH7 c. oozingH14 = oozingH7 d. tepiH14 < tepiH7 e. tepiH14 > tepiH7 f. tepiH14 = tepiH7
g. LeukositH14 < LeukositH7 h. LeukositH14 > LeukositH7 i. LeukositH14 = LeukositH7 j. BesarLukaH14 < BesarlukaH7 k. BesarLukaH14 > BesarlukaH7 l. BesarLukaH14 = BesarlukaH7
Test Statisticsa oozingH14 -
oozingH7
tepiH14 - tepiH7 LeukositH14 - LeukositH7
BesarLukaH14 - BesarlukaH7
Z ,000b -1,000c ,000b -2,041c
Asymp. Sig. (2-tailed) 1,000 ,317 1,000 ,041
a. Wilcoxon Signed Ranks Test
b. The sum of negative ranks equals the sum of positive ranks.
c. Based on positive ranks.
NPar Tests (basitracin-neomisin) Wilcoxon Signed Ranks Test
Ranks
N Mean Rank Sum of Ranks
oozingH14 - oozingH7
Negative Ranks 0a ,00 ,00
Positive Ranks 1b 1,00 1,00
Ties 4c
Total 5
tepiH14 - tepiH7
Negative Ranks 3d 2,00 6,00
Positive Ranks 0e ,00 ,00
Ties 2f
Total 5
LeukositH14 - LeukositH7
Negative Ranks 0g ,00 ,00
Positive Ranks 0h ,00 ,00
Ties 5i
Total 5
BesarLukaH14 - BesarlukaH7
Negative Ranks 5j 3,00 15,00
Positive Ranks 0k ,00 ,00
Ties 0l
Total 5
a. oozingH14 < oozingH7 b. oozingH14 > oozingH7 c. oozingH14 = oozingH7 d. tepiH14 < tepiH7
e. tepiH14 > tepiH7 f. tepiH14 = tepiH7
g. LeukositH14 < LeukositH7 h. LeukositH14 > LeukositH7 i. LeukositH14 = LeukositH7 j. BesarLukaH14 < BesarlukaH7 k. BesarLukaH14 > BesarlukaH7 l. BesarLukaH14 = BesarlukaH7
Test Statisticsa oozingH14 -
oozingH7
tepiH14 - tepiH7 LeukositH14 - LeukositH7
BesarLukaH14 - BesarlukaH7
Z -1,000b -1,732c ,000d -2,121c
Asymp. Sig. (2-tailed) ,317 ,083 1,000 ,034
a. Wilcoxon Signed Ranks Test b. Based on negative ranks.
c. Based on positive ranks.
d. The sum of negative ranks equals the sum of positive ranks.
NPar Tests (kontrol)
Wilcoxon Signed Ranks Test
Ranks
N Mean Rank Sum of Ranks
oozingH14 - oozingH7
Negative Ranks 0a ,00 ,00
Positive Ranks 5b 3,00 15,00
Ties 0c
Total 5
tepiH14 - tepiH7
Negative Ranks 0d ,00 ,00
Positive Ranks 3e 2,00 6,00
Ties 2f
Total 5
LeukositH14 - LeukositH7
Negative Ranks 0g ,00 ,00
Positive Ranks 0h ,00 ,00
Ties 5i
Total 5
BesarLukaH14 - BesarlukaH7
Negative Ranks 5j 3,00 15,00
Positive Ranks 0k ,00 ,00
Ties 0l
Total 5
a. oozingH14 < oozingH7 b. oozingH14 > oozingH7 c. oozingH14 = oozingH7 d. tepiH14 < tepiH7 e. tepiH14 > tepiH7 f. tepiH14 = tepiH7
g. LeukositH14 < LeukositH7 h. LeukositH14 > LeukositH7 i. LeukositH14 = LeukositH7 j. BesarLukaH14 < BesarlukaH7 k. BesarLukaH14 > BesarlukaH7 l. BesarLukaH14 = BesarlukaH7
Test Statisticsa oozingH14 -
oozingH7
tepiH14 - tepiH7 LeukositH14 - LeukositH7
BesarLukaH14 - BesarlukaH7
Z -2,236b -1,732b ,000c -2,023d
Asymp. Sig. (2-tailed) ,025 ,083 1,000 ,043
a. Wilcoxon Signed Ranks Test b. Based on negative ranks.
c. The sum of negative ranks equals the sum of positive ranks.
d. Based on positive ranks.